GLATIRAMER vs GLOFITAMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
GLATIRAMER vs GLOFITAMAB: Safety Overview
| Metric | GLATIRAMER | GLOFITAMAB |
|---|---|---|
| Total FAERS Reports | 46,357 | 1,116 |
| Deaths Reported | 696 | 315 |
| Death Rate | 1.5% | 28.2% |
| Hospitalizations | 5,831 | 492 |
| Average Patient Age | 48.4 yrs | 62.5 yrs |
| % Female Patients | 81.0% | 53.2% |
| FDA Approval Date | Apr 16, 2015 | N/A |
| Manufacturer | Zydus Pharmaceuticals USA Inc. | Genentech, Inc. |
| Route | SUBCUTANEOUS | INTRAVENOUS |
| Marketing Status | Discontinued | N/A |